Vanadium compounds, in particular organic derivatives, are effective oral insulinomimetics, which inhibit lipolysis, decrease blood glucose levels (BGL) in animals and in clinical trials, and stimulate insulin secretion in experimental models of Diabetes Mellitus (DM) [1]–[5]. The gene discussed is INS; the disease is diabetes mellitus.